Allele and Genotype Frequencies of the ABO Blood
Group System in a Palestinian Population
DECLARATION
The work provided in this thesis unless otherwise referenced is the
researchers own work and has not been submitted elsewhere for any other
degree or qualification
Students name لمياء صبحي صقراسم الطالب
Lamiaa Signature التوقيع
Date 2013 التاريخ
ii
Allele and Genotype Frequencies of the ABO Blood
Group System in a Palestinian Population
Prepared by
Lamiaa Sobhi Saqer
Supervisor
Prof Fadel A Sharif
A Thesis Submitted in Partial Fulfillment of the Requirements for the
Degree of Master in Biological Sciences Medical Technology
1434هـ -2013م
The Islamic University ndash Gaza
Deanery of Higher Education
Faculty of Science
Master of Biology Sciences
Medical Technology
iii
i
Abstract
The ABO blood group antigens are of clinical importance in blood transfusion organ
transplantation autoimmune hemolytic anemia and fetomaternal blood group
incompatibility The ABO locus are located on chromosome 9 Till now more than 200
ABO alleles have been identified by molecular investigations The objective of this
study was to determine the major ABO alleles and genotypes frequencies in a
Palestinian population residing in Gaza Strip A four separatendashreaction multiplex allele
specific polymerase chain reaction (AS-PCR) was used to determine the ABO
genotypes Our study population consisted of 201 unrelated subjects (50 males and 151
females) whose DNA extracted from peripheral blood was subjected to genotyping
The genotypes of 201 samples were found to be A1A1 (n=3) A1O 1(n=24) A1O2 (n=25)
A1A2 (n=4) A2A2 (n=2) A2O1 (n=13) A2O2 (n=2) B1B1 (n=5) B1O1 (n=26) B1O2 (n=14)
A1B (n=11) A2B (n=4) O1O1 (n=31) O1O2 (n=26) and O2O2 (n=11) from which the
deduced phenotypes were A (n=73) B (n=45) AB (n=15) and O (n=68)Moreover
there was no significant difference between observed and expected genotypes and the
genotyping results were consistent with Hardy-Weinberg law The frequencies of A1
A2 B1 O1 and O2 alleles were 0 174 0067 0162 0376 and 0221 respectively The
rare cis-ABO1 allele was not encountered in the study population The genotype results
were compared with serologically determined phenotypes and there were no deviation
To our knowledge this is the first study in Gaza strip investigating the ABO genotypes
ABO genotyping has practical applications in blood transfusion tissueorgan
transplantation blood typing discrepancies and forensicpaternity testing investigations
Key words
ABO alleles ABO genotypes AS-PCR allele frequencies ABO phenotype
ii
ABO
ABO
ABO
Antisera
DNA AS-PCR
A1A1A1O1
A1O2 A1A2 A2A2A2O1A2O2B1B1B1O1B1O2
A1BA2BO1O1O1O2O2O2A
BAB
O A1 A2
B O1O2cis-ABO1
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
ii
Allele and Genotype Frequencies of the ABO Blood
Group System in a Palestinian Population
Prepared by
Lamiaa Sobhi Saqer
Supervisor
Prof Fadel A Sharif
A Thesis Submitted in Partial Fulfillment of the Requirements for the
Degree of Master in Biological Sciences Medical Technology
1434هـ -2013م
The Islamic University ndash Gaza
Deanery of Higher Education
Faculty of Science
Master of Biology Sciences
Medical Technology
iii
i
Abstract
The ABO blood group antigens are of clinical importance in blood transfusion organ
transplantation autoimmune hemolytic anemia and fetomaternal blood group
incompatibility The ABO locus are located on chromosome 9 Till now more than 200
ABO alleles have been identified by molecular investigations The objective of this
study was to determine the major ABO alleles and genotypes frequencies in a
Palestinian population residing in Gaza Strip A four separatendashreaction multiplex allele
specific polymerase chain reaction (AS-PCR) was used to determine the ABO
genotypes Our study population consisted of 201 unrelated subjects (50 males and 151
females) whose DNA extracted from peripheral blood was subjected to genotyping
The genotypes of 201 samples were found to be A1A1 (n=3) A1O 1(n=24) A1O2 (n=25)
A1A2 (n=4) A2A2 (n=2) A2O1 (n=13) A2O2 (n=2) B1B1 (n=5) B1O1 (n=26) B1O2 (n=14)
A1B (n=11) A2B (n=4) O1O1 (n=31) O1O2 (n=26) and O2O2 (n=11) from which the
deduced phenotypes were A (n=73) B (n=45) AB (n=15) and O (n=68)Moreover
there was no significant difference between observed and expected genotypes and the
genotyping results were consistent with Hardy-Weinberg law The frequencies of A1
A2 B1 O1 and O2 alleles were 0 174 0067 0162 0376 and 0221 respectively The
rare cis-ABO1 allele was not encountered in the study population The genotype results
were compared with serologically determined phenotypes and there were no deviation
To our knowledge this is the first study in Gaza strip investigating the ABO genotypes
ABO genotyping has practical applications in blood transfusion tissueorgan
transplantation blood typing discrepancies and forensicpaternity testing investigations
Key words
ABO alleles ABO genotypes AS-PCR allele frequencies ABO phenotype
ii
ABO
ABO
ABO
Antisera
DNA AS-PCR
A1A1A1O1
A1O2 A1A2 A2A2A2O1A2O2B1B1B1O1B1O2
A1BA2BO1O1O1O2O2O2A
BAB
O A1 A2
B O1O2cis-ABO1
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
iii
i
Abstract
The ABO blood group antigens are of clinical importance in blood transfusion organ
transplantation autoimmune hemolytic anemia and fetomaternal blood group
incompatibility The ABO locus are located on chromosome 9 Till now more than 200
ABO alleles have been identified by molecular investigations The objective of this
study was to determine the major ABO alleles and genotypes frequencies in a
Palestinian population residing in Gaza Strip A four separatendashreaction multiplex allele
specific polymerase chain reaction (AS-PCR) was used to determine the ABO
genotypes Our study population consisted of 201 unrelated subjects (50 males and 151
females) whose DNA extracted from peripheral blood was subjected to genotyping
The genotypes of 201 samples were found to be A1A1 (n=3) A1O 1(n=24) A1O2 (n=25)
A1A2 (n=4) A2A2 (n=2) A2O1 (n=13) A2O2 (n=2) B1B1 (n=5) B1O1 (n=26) B1O2 (n=14)
A1B (n=11) A2B (n=4) O1O1 (n=31) O1O2 (n=26) and O2O2 (n=11) from which the
deduced phenotypes were A (n=73) B (n=45) AB (n=15) and O (n=68)Moreover
there was no significant difference between observed and expected genotypes and the
genotyping results were consistent with Hardy-Weinberg law The frequencies of A1
A2 B1 O1 and O2 alleles were 0 174 0067 0162 0376 and 0221 respectively The
rare cis-ABO1 allele was not encountered in the study population The genotype results
were compared with serologically determined phenotypes and there were no deviation
To our knowledge this is the first study in Gaza strip investigating the ABO genotypes
ABO genotyping has practical applications in blood transfusion tissueorgan
transplantation blood typing discrepancies and forensicpaternity testing investigations
Key words
ABO alleles ABO genotypes AS-PCR allele frequencies ABO phenotype
ii
ABO
ABO
ABO
Antisera
DNA AS-PCR
A1A1A1O1
A1O2 A1A2 A2A2A2O1A2O2B1B1B1O1B1O2
A1BA2BO1O1O1O2O2O2A
BAB
O A1 A2
B O1O2cis-ABO1
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
i
Abstract
The ABO blood group antigens are of clinical importance in blood transfusion organ
transplantation autoimmune hemolytic anemia and fetomaternal blood group
incompatibility The ABO locus are located on chromosome 9 Till now more than 200
ABO alleles have been identified by molecular investigations The objective of this
study was to determine the major ABO alleles and genotypes frequencies in a
Palestinian population residing in Gaza Strip A four separatendashreaction multiplex allele
specific polymerase chain reaction (AS-PCR) was used to determine the ABO
genotypes Our study population consisted of 201 unrelated subjects (50 males and 151
females) whose DNA extracted from peripheral blood was subjected to genotyping
The genotypes of 201 samples were found to be A1A1 (n=3) A1O 1(n=24) A1O2 (n=25)
A1A2 (n=4) A2A2 (n=2) A2O1 (n=13) A2O2 (n=2) B1B1 (n=5) B1O1 (n=26) B1O2 (n=14)
A1B (n=11) A2B (n=4) O1O1 (n=31) O1O2 (n=26) and O2O2 (n=11) from which the
deduced phenotypes were A (n=73) B (n=45) AB (n=15) and O (n=68)Moreover
there was no significant difference between observed and expected genotypes and the
genotyping results were consistent with Hardy-Weinberg law The frequencies of A1
A2 B1 O1 and O2 alleles were 0 174 0067 0162 0376 and 0221 respectively The
rare cis-ABO1 allele was not encountered in the study population The genotype results
were compared with serologically determined phenotypes and there were no deviation
To our knowledge this is the first study in Gaza strip investigating the ABO genotypes
ABO genotyping has practical applications in blood transfusion tissueorgan
transplantation blood typing discrepancies and forensicpaternity testing investigations
Key words
ABO alleles ABO genotypes AS-PCR allele frequencies ABO phenotype
ii
ABO
ABO
ABO
Antisera
DNA AS-PCR
A1A1A1O1
A1O2 A1A2 A2A2A2O1A2O2B1B1B1O1B1O2
A1BA2BO1O1O1O2O2O2A
BAB
O A1 A2
B O1O2cis-ABO1
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
ii
ABO
ABO
ABO
Antisera
DNA AS-PCR
A1A1A1O1
A1O2 A1A2 A2A2A2O1A2O2B1B1B1O1B1O2
A1BA2BO1O1O1O2O2O2A
BAB
O A1 A2
B O1O2cis-ABO1
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
iii
TABLE OF CONTENTS CONTENTS Page
ABSTRACT (English)------------------------------------------------------------------------- i
ABSTRACT (Arabic)-------------------------------------------------------------------------- ii
TABLE OF CONTENTS--------------------------------------------------------------------- iii
LIST OF TABLES----------------------------------------------------------------------------- v
LIST OF FIGURES---------------------------------------------------------------------------- vi
ABBREVIATIONS----------------------------------------------------------------------------- vii
DEDICATION---------------------------------------------------------------------------------- x
ACKNOWLEDGEMENTS------------------------------------------------------------------ xi
CHAPTER 1
INTRODUCTION------------------------------------------------------------------------------
1
11 Background-------------------------------------------------------------------------------- 2
12 Objectives of the Study------------------------------------------------------------------ 4
121 General Objective-------------------------------------------------------------------- 4
122 Specific objectives------------------------------------------------------------------- 4
CHAPTER 2
LITIRATURE REVIEW---------------------------------------------------------------------
6
21 Background-------------------------------------------------------------------------------- 6
22 Biosynthesis of ABH antigens---------------------------------------------------------- 6
221 H antigen------------------------------------------------------------------------------ 8
222 A and B antigens------------------------------------------------------------------- 9
23 ABO Glycosyltransferases------------------------------------------------------------- 11
24 ABO Subgroups-------------------------------------------------------------------------- 11
241 A and B Subgroups ----------------------------------------------------------------- 11
2411 A Subgroups --------------------------------------------------------------------- 12
2412 B Subgroups---------------------------------------------------------------------- 13
242 O Subgroups-------------------------------------------------------------------------- 13
243 Weak subgroups-------------------------------------------------------------------- 14
2431 Weak A alleles-------------------------------------------------------------------- 15
2432 Weak B alleles-------------------------------------------------------------------- 15
25 ABO antibodies-------------------------------------------------------------------------- 17
26 Studies on ABO Genotypes------------------------------------------------------------ 18
27 ABO Genotyping and susceptibility to diseases------------------------------------- 22
CHAPTER 3
MATERIALS and METHODS--------------------------------------------------------------
24
31 Materials---------------------------------------------------------------------------------- 24
311 PCR primers-------------------------------------------------------------------------- 24
312 Kits------------------------------------------------------------------------------------- 25
313 Reagents and Chemicals------------------------------------------------------------ 25
314 Apparatus and Equipments--------------------------------------------------------- 25
32 Methods------------------------------------------------------------------------------------ 26
321 Study population--------------------------------------------------------------------- 26
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
iv
TABLE OF CONTENTS CONTENTS Page
322 Sample collection------------------------------------------------------------------- 26
323 Ethical Considerations------------------------------------------------------------- 26
324 Data Analysis-------------------------------------------------------------------------- 26
33Blood ABO-typing---------------------------------------------------------------------- 26
331 Forward blood group----------------------------------------------------------------- 26
34 ABO Genotyping------------------------------------------------------------------------ 27
341 DNA Extraction---------------------------------------------------------------------- 27
342 Detection of extracted DNA-------------------------------------------------------- 28
35 PCR reactions---------------------------------------------------------------------------- 28
351 Temperature cycling program------------------------------------------------------ 29
352 Expected PCR results---------------------------------------------------------------- 29
CHAPTER 4
RESULTS----------------------------------------------------------------------------------------
31
41 Study Population------------------------------------------------------------------------- 31
42 Phenotypic Frequency of ABO Blood Groups--------------------------------------- 31
43 The Allele Frequencies of ABO Antigens----------------------------------------- 32
44 PCR Results------------------------------------------------------------------------------- 33
441 Quality of the isolated DNA-------------------------------------------------------- 33
442 Blood group genotyping by allele specific PCR-------------------------------- 33
443 Genotype Frequencies--------------------------------------------------------------- 36
CHAPTER 5
DISCUSSION-----------------------------------------------------------------------------------
39
CHAPTER 6
CONCLUSION and RECOMMENDATIONS-------------------------------------------
43
CHAPTER 7
REFERENCES----------------------------------------------------------------------------------
45
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
v
List of Tables Table Page
Table 21 Some of Human blood group systems recognized by the ISBT----- 6
Table 22 Serological reaction patterns------------------------------------------------- 15
Table 23 Characteristics of some more frequent B weak phenotypes----------------- 16
Table 31 PCR primers sequences used for ABO genotype---------------------- 24
Table 32 Sample Anti A Anti B reaction for forward blood grouping------- 27
Table 32 Composition of PCR master mix----------------------------------------- 29
Table 41 Phenotypic frequencies of various blood groups in the studied
population-------------------------------------------------------------------
31
Table 42 Observed and expected genotypes for the 201 samples -------------- 32
Table 43 PCR products according to the genotype-------------------------------- 34
Table 44 The frequency of recognized genotypes using multiplex AS-PCR
method for population residing in Gaza Strip--------------------------
37
Table 51 Frequency of ABO alleles in Gaza Strip in comparison to some
other countries--------------------------------------------------------------
41
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
vi
List of Figures Figure Page
Figure 11 Schematic representation of the genomic organization of the ABO
locus-------------------------------------------------------------------------- 2
Figure 21 Biosynthesis of ABO Antigens------------------------------------------- 8
Figure 22 H antigen structure--------------------------------------------------------- 9
Figure 23 A B and O(H) blood group structures and their synthesis----------- 10
Figure 24 A and B antigen structure------------------------------------------------- 10
Figure 41 Distribution of the subjects according to gender----------------------- 13
Figure 42 Gel electrophoresis for DNA extracted from human blood
samples----------------------------------------------------------------------
33
Figure 43 The electrophoresis pattern of recognized genotypes using the
multiplex AS-PCR method------------------------------------------------
36
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
vii
ABBREVIATIONS
A Adenine
aa Amino acid
Ala Alanine
Arg Arginine
Asn Asparagine
Asp Aspartic acid
AS-PCR Allele Specific ndash Polymerase Chain Reaction
BGMUT Blood Group antigen gene Mutation database
bp Base pair
degC Celsius
C Cytosine
C-2 position Carbon -2 position
CAZy Carbohydrate Active enZyme
cDNA Complementary DNA
C-terminus Carbon terminus
dATP deoxyadenosine Triphosphate
dCTP deoxyacytidine Triphosphate
dGTP deoxyguanosine Triphosphate
dNTPs Deoxynucleotide Triphosphates
dTTP deoxytymidine triphosphate
Del deletion
E coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
Fuc Fucose
FUT fucosyltransferases
G Guanine
Gal Galactose
GalNAc N-acetylgalactosamine
GalNAcα3 N-acetylgalactosylamine
Galα3 galactosyl
GDP guanosine diphosphate
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
viii
Glc glucose
GlcNAc N-acetylglucosamine
Glu Glutamic acid
Gly Glycine
GTA Glycosyltransferases A
GTB Glycosyltransferases B
GTs Glycosyltransferases
Ile Isoleucine
ISBT International Society of Blood Transfusion
kb Kilo base
Leu Leucine
Met Methionine
mf Mixed field
ml Milliliter
Mn++ Manganese
microl Micro liter
nt nucleotide
MTHFR Methylenetetrahydrofolate reductase
PCR Polymerase chain reaction
PCR-SSCP PCR- Single-Strand Conformation Polymorphism
Phe Phenylalanine
pmol picomole
Pro Proline
RBCs Red Blood Cells
RFLP Restriction Fragment Length Polymorphism
rpm Round per minute
Ser Serine
SNP Single ndash Nucleotide polymorphism
SSP Sequence-Specific Primers
SPSS Statistical Package for Social Sciences
T Thymine
Trp Tryptophan
UV Ultra Violet
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
ix
UDP uridine diphosphate
UDP-Gal uridine diphosphate galactose
UDP-GalNAc uridine diphosphate N-acetylgalactosamine
Val Valine
VTE Venous thromboembolism
vWF von Willebrand factor
w weak
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
x
To my family especially my parents
for their continuous encouragement
and unlimited support to all those who
enliven my days and brighten my ways
To whom who change my life
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
xi
Acknowledgments
This work has been carried out in the Genetic Diagnosis Laboratory at the
Islamic university of Gaza Palestine
First and for most I am thankful to his almighty God for this work To those
people who directly or indirectly helped a lot to make this work perfect
I wish to express my gratitude and deepest thanks to his Excellency
Professor Fadel A Sharif to his initiating planning supervision and scientific
guidance of this work He stand with me step by step and he was very keen to
teach me every thing right
My thanks and appreciation to V Dean for Academic AffairsndashCollege of science
and technology Mr Niddal S Abu hujayer for his great help and support
I would like to extend my thanks to the staff of the college of science and
technology especially the Medical Sciences department Khan Younis where I
am working for their support
I am grateful too for the support and advise from Mr Ahmad S Silmi for
his assistance advice and support
I am deeply grateful to Mr Mohammad J Ashour for his helpful and
friendly support during the laboratory work
Finally I want to thank my family parents brothers and sisters who
they always stood beside me and gave me encouragement all the time
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
3
CHAPTER 1
INTRODUCTION
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
2
CHAPTER 1
INTRODUCTION
11 Background
In clinical practice the ABO blood group system is one of the most important
since the A and B epitopes may provoke a strong immune reaction With the
introduction of blood typing and cross-matching techniques blood transfusion became
not only a simple but also a much safer procedure Furthermore although ABO typing
reduced the occurrence of transfusion reactions they still occurred indicating the
presence of other genetic differences in blood groups of importance in transfusion
medicine as well as in the later emerging field of organ transplantation(1)
Human ABO locus is located in chromosome 9q341-q342 (2-5) and consists of 7 exons
distributed over 18 kb of genomic DNA ranging in size from 28 to 688 base pairs (bp)
and 6 introns with 554 to 12982 bp (6-8) (Figure 11) Exon 7 contains most of the
largest coding sequence whereas exon 6 contains the deletion found in most O alleles
(9)
Figure 11 Schematic representation of the genomic organization of the ABO gene (10)
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
1
Molecular genetic studies of human ABO genes have demonstrated that ABO genes
have two critical single base substitutions in the last coding exon that result in amino
acid substitutions responsible for the different donor nucleotide sugar substrate
specificity between A- and B-transferases A single base deletion in exon 6 was
ascribed to shift the reading frame of codons and to abolish the transferase activity of A-
transferase in most O alleles (45911)
ABO genotyping is important not only for blood transfusion but also for tissuecell and
organ transplantations Also ABO genotypes are important evidence at crime scenes
and for personal identification in forensic investigations and paternity testing
To our knowledge this is the first study in Gaza Strip investigating the ABO gene
polymorphism In this study multiplex allele-specific PCR is used for determining the
ABO genotypes and the corresponding allele frequency in a group of 201 unrelated
Palestinians residing in Gaza Strip
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
4
12 Objectives of the Study
121 General Objective
To determine the major ABO alleles and genotypes frequencies in a Palestinian
population residing in Gaza Strip
122 Specific objectives
1- To employ PCR and Allele-specific (AS)-PCR for molecular genotyping of ABO
blood system
2- To correlate ABO genotypes with phenotypes in blood samples of Gaza Strip
population
3- To compare the frequency of ABO genotypes with other populations
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
5
CHAPTER 2
LITIRATURE REVIEW
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
6
CHAPTER 2
LITIRATURE REVIEW
21 Background
The International Society of Blood Transfusion (ISBT) Working Committee on
Terminology for Red Cell Surface Antigens was set up in 1980 to establish and define a
meaningful nomenclature for different blood groups (12) Every valid blood group
antigen is given a six digit identification number There are 29 different systems to date
and the first three digits represent the systems (001-029)
The symbol for a gene or cluster of genes controlling a blood group system is
often the italicized symbol for the system The ABO genotypes should consequently be
written in italicized capital letters (Table 21)
Table 21 Some of Human blood group systems recognized by the ISBT (12)
No Name Symbol No of
antigens
Gene name(s) Chromosome
001 ABO ABO 4 ABO 9
002 MNS MNS 43 GYPA GYPB GYPE 4
003 P P1 1 P1 22
004 Rh RH 49 RHD RHCE 1
005 Lutheran LU 19 LU 19
006 Kell KEL 25 KEL 7
007 Lewis LE 6 FUT3 19
008 Duffy FY 6 DARC 1
009 Kidd JK 3 SLC14A1 18
22 Biosynthesis of ABH antigens
The biochemical basis of the ABO and H antigens is well understood due to
intensive studies during the 1950s and 1960s by the pioneering work on ovarian cyst
fluids (which contain large amounts of water-soluble blood-group-active glycoproteins)
by Morgan amp Watkins and Kabat The ABO antigens are not limited to erythroid
tissues but are also found in different tissues and on some epithelial cells (13)The
antigens are also present in the secretory fluids in the majority of humans therefore they
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
7
can sometimes be noted as histo-blood group antigens (14) ABH antigens are
carbohydrate structures These oligosaccharide chains are generally conjugated with
polypeptides to form glycoproteins Oligosaccharides are synthesized in a stepwise
fashion the addition of each monosaccharide being catalyzed by a specific
glycosyltransferase enzyme (15)
The glycoproteins contain a peptide backbone to which multiple oligosaccharide
chains are attached through an alkali-labile glycosidic bond (1617) to the hydroxyl
group of serine or threonine (18) Most of the oligosaccharide chains are linked to the
backbone through an N-acetylgalactosamine residue The carbohydrate moiety of the
ABH glycoproteins consists primarily of four sugars D-galactose L-fucose N-acetyl-
D-galactosamine and N-acetyl-D-glucosamine (19) The amino acid compositions of the
different blood group glycoproteins are similar to each other and unrelated to blood-
group specificity
Expression of H A and B antigens is dependent on the presence of specific
monosaccharides attached to various precursor disaccharides at the non-reducing end of
a carbohydrate chain (14) A transferase product of A allele transfers the
monosaccharide N acetylgalactosamine from the donor substrate uridine diphosphate
(UDP)-N-acetylgalactosamine to the fucosylated galactosyl residue of the H antigen to
produce an active structure The B transferase product of B allele transfers galactose
from UDP-galactose to the fucosylated galactose of H to produce a B-active structure
(20)Individuals with the gene for Glycosyltransferases A have blood group A those
with the gene for Glycosyltransferases B have blood group B those with genes for both
enzymes or a cis-acting form of GTA or GTB have blood type AB and those with a
mutated inactive form of enzyme have blood group O (Figure 21 )
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
8
Figure 21 Biosynthesis of ABO Antigens (2)
The major alleles at the ABO locus are A B and O and to-date a number of ABO
blood groups variants have been reported with approximately 250 different alleles
registered in the Blood Group antigen gene Mutation database BGMUT (21)
221 H antigen
In nature there exists at least four H antigens on glycolipids and glycoproteins
that are recognized by GTA and GTB (22)The most common are the type I and the type
II H antigens (23)H antigen is produced when an α12-Lfucosyltransferase catalyses the
transfer of L-fucose from a guanosine diphosphate (GDP)-L-fucose donor to the C-2
position of the terminal galactose of one of the precursor structures (Figure 21) Two
α12-L-fucosyltransferases produced by two genes FUT1 (H) and FUT2 (Se) catalyze
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
9
the biosynthesis of H-active structures in different tissues (24) mainly in epithelial cells
and body fluids such as saliva
The H antigen (Figure 22) is the natural precursor of A and B antigens and its
fucose residue is required for A and B glycosyltransferases to recognize it as the
acceptor and transfer GalNAc or Gal to its terminal Gal Depending on the disaccharide
precursor core chain on which ABH determinants are synthesized they can be further
divided into different types
Figure 22 H antigen structure
Everybody expresses H antigen on his red cells but only about 80 of
Europeans have H antigen in their body secretions These people are called ABH
secretors because if they have an A andor B gene they also secrete A andor B
antigens The remaining 20 are called ABH non-secretors as they do not secrete H A
or B regardless of ABO genotype (2526)
222 A and B antigens
A and B antigens can be produced by the presence of the appropriate A- or B
transferase (Figure 21) The A gene product is an α13-N-acetyl galactosaminyl-
transferase which transfers N-acetyl-galactosamine from a uridine diphosphate (UDP)-
N acetylgalactosamine donor to the fucosylated galactosyl residue of H antigen The B
gene product an α 13-D-galactosyltransferase transfers D-galactose from UDP-
galactose to the fucosylated galactose of H A and B are alleles at the ABO locus on
chromosome 9 A third allele O does not produce an active enzyme and in persons
homozygous for O the H antigen remains unmodified (Figure 23)
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
31
Figure 23 Summary of A B and O(H) blood group structures and their synthesis(28)
The A and B antigens are carbohydrate molecules built stepwise from
saccharides such as galactosamine (GalNAc) glucosamine (GlcNAc) fucose (Fuc)
galactose (Gal) and glucose (Glc) H-antigen is the requisite precursor and
galactosylamine (GalNAcα3) or galactosyl (Galα3) with α1-3 linkage onto H antigen
become the A and B antigens respectively (514) (Figure 24)
Figure 24 A and B antigen structure
The majority of ABO antigens on red cells are linked to glycoproteins
(approximately 70) thus they very much influence the blood group activity on the red
cells At each step in the biosynthesis of ABO antigens and carbohydrate chains
synthesis is facilitated by glycosyltransferases which are competing for available
precursors and substrates This represents approximately 80 of the total complement
of red cell ABH determinants Another 5 times 105 ABH determinants localize to the red
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
33
cell glucose transport protein (Band 45) Small numbers of ABH antigens are also
expressed by other red cell glycoproteins (28)
23 ABO Glycosyltransferases
Glycosyltransferases (GTs) constitute a large family of enzymes that are
involved in the biosynthesis of oligosaccharides polysaccharides and glycoconjugates
(29)Particularly abundant are the GTs that transfer a sugar residue from an activated
nucleotide sugar donor to specific acceptor molecules forming glycosidic bonds
Glycosyltransferases are classified into 87 different families based on substrateproduct
stereochemistry according to the CAZy database (30)
Knowledge of the sequences of the ABO genes (9) have established that
mammalian Glycosyltransferases A and Glycosyltransferases B are type II integral
membrane proteins containing 354 amino acids and are localized in the lumen of the
Golgi apparatus These enzymes typically have a short amino-terminal cytoplasmic tail
a hydrophobic membrane domain a short protease-sensitive stem region and a large
catalytic domain that includes the carboxy terminus(31) GTA and GTB are very similar
in the coding regions and the soluble enzyme can be found in serum (32)urine (33)and
milk (34)The enzyme contains an acceptor recognition domain that binds H antigen and
a donor recognition domain that binds UDP-GalNAc or UDP-Gal GTA and GTB
require the metal ion Mn++ (manganese) for activity (35)
Glycosyltransferases are antigenic structures Human antibodies to blood group
transferases are often produced following organ transplantation (36-39)
24 ABO Subgroups
241 A and B Subgroups
An ABO blood group subtype is called a subgroup andor a variant Subgroups
of ABO are distinguished by decreased amounts of A B or O (H) antigens on red blood
cells The most common are subgroups of A and B Blood type A appears to have the
most variation in subgroups The two most common subgroups of blood group A are A1
and A2 expressing on average 1 million and 250 000 A determinants respectively (40)
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
32
2411 A Subgroups
The A1 (A101) allele is the reference allele often denoted as the consensus
sequence in an ABO genotype context (9)but has additionally eight variant alleles
There are variants of A1 alleles one of which is very common in Asian populations with
a 467CrarrT (A102) polymorphism resulting in the substitution Pro156Leu (41)Two
minor A1 alleles (A103 and A104) have been described and differ as follows The first
one also has the 467CrarrT point mutation but an additional silent mutation 567CrarrT
the second allele contains a silent polymorphism in nucleotide 297ArarrG (42) A105 is
like A102 with the same mutation in exon 7 467CrarrT but analysis of intron 6 showed
additional single-nucleotide polymorphism (SNP) compared to A102 Another A1 allele
(A106) contains both 297ArarrG and 467CrarrT (43)
The A2 subgroup is the most common A phenotype after the A1 subgroup The
main genetic difference between A1 and A2 alleles is one point mutation in exon 7
467CrarrT (Pro156Leu) and a deletion of one of the three cytosines at nt 1059-1061
(CCC to CC) The latter mutation results in an extension of the reading frame by 64
nucleotides This deletion occurs in the codon before the translation stop codon (TGA)
resulting in a gene product with an extra 21 amino acid at its C-terminus The
glycosyltransferases encoded by the A2 allele have lower efficiency leading to a weaker
A phenotype The enzyme activity is decreased by 30-50 times compared to A1
(22)Other variants of A2 alleles have subsequently been elucidated (A202-206) Three
A2-like alleles were shown to have three different single mutations near the 3acute end of
exon 7 by Ogasawara A2-2 (A202) contains 1054CrarrT (Arg352Trp) A2-3 (A203) with
1054CrarrG (Arg352Gly) (42) and A2-4 (A205) with both 467CrarrT and an additional
new mutation 1009ArarrG (Arg337Gly) (44) A204 with four common B-related base
substitutions (297ArarrG 526CrarrG 657CrarrT and 703GrarrA) seems to be a hybrid with
two extra substitutions 771CrarrT (silent mutation) and 829GrarrA (Val277Met) One
other rare A2 subgroup A2-5 (A206) carried only the single deletion (1061delC)
(4546)
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
31
2412 B Subgroups
Subtypes of blood type B are classified by the quantity of B antigen and the
amount of B antigen decreases in the order B B3 Bx Bm Bel B1 allele (B101)
showed seven single nucleotide substitutions 297 526 657 703 796 803 and 930
throughout exon 6 and 7 and later one extra mutation outside the coding region at the 3acute
end at nt 1096 (33) The four amino acids substitutions governed by nt 526CrarrG
(Arg176Gly) 703GrarrA (Gly235Ser) 796CrarrA (Leu266Met) and 803GrarrC
(Gly268Ala) discriminate GTA from GTB (4147) while the substitutions 297 657 and
930 are silent
ABO glycosyltransferases can accordingly be described by using the letters A
and B to illustrate the derivation of the amino acid at these four residues GTA would be
represented by AAAA indicating the presence of ArgGlyLeuGly and similarly BBBB
would describe the GTB with GlySerMetAla at residues 176235266 and 268
respectively The substitutions at positions 266 and 268 were shown to be responsible
for the nucleotidedonor specificity of the transferases (47) and the other residues may
have a role in acceptor binding and turnover (48)Some other variants have been
reported afterwards that differ from B1 (B101) by lacking the 930 substitution for B2
(B102) the 657 substitution for B3 (B103) (47) the 526 substitution for B4 (B107) (44)
and 297 for B108 (43)
242 O Subgroups
The blood group O demonstrates the absence of A and B antigens on the RBC
surface in forward blood typing Reverse blood typing indicates the presence of both
anti-A and -B in the plasma The first O allele (O1-1 [O01]) was shown to be identical
to the consensus A allele (A101) except for a nucleotide deletion 261delG in exon 6
This results in a shift in the reading frame giving rise to a truncated protein that alters
the protein sequence after amino acid 88 A stop codon halts translation after amino acid
117 and the resulting protein is enzymatically inactive (41) Some other O1-1-like
alleles that are characterized by the presence of the 261delG and at least one additional
point mutation A second kind of O allele has the same inactivating deletion (261delG)
as the original O allele (O1-1 [O01]) but in addition has nine point mutations spread
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
34
throughout exons 3 to 7 (4145) and a further 13 mutations have been found amongst
the intron 6 (50)
Additional polymorphisms associated with blood group O have been found up to
approximately 4300 bp from ABO exon 7 (51) some of which correlated with O1 and
O1v alleles (52) Other O alleles not due to 261delG also exist that are caused by other
inactivating mutations along the reading frame The ( O2-1 [O03]) was the first allele
described of this type (5354) which has a critical mutation (802G rarr A) causing an
amino acid change (Gly268Arg) that prevents the enzyme from utilizing the nucleotide
sugar donor (55) This O allele comprises approximately 2 to 5 percent of O alleles in
Caucasian persons but seems to be absent or at least very rare in other populations
(5456) Other rare O alleles such as O3 [O08] that does not have 261delG but instead
contains both the common A2 allele polymorphisms 467CrarrT and C-deletion at nt
1059-1061 and an insertion of an extra guanosine in the 7-guanosine sequence at nt
798-804 (45) Two other rare O alleles lacking 261delG were reported in the Japanese
population by Ogasawara O301 [O14] has the missense mutation 893CrarrT (Ala268Val)
on an A102 background whereas O302 [O15] has the nonsense mutation 927CrarrA
(Tyr309Stop) on an A101 background (43)
243 Weak subgroups
In addition to the major phenotypes characterized by either strong or absent
haemagglutination with anti-A-A1 and -B reagents the ABO blood group system also
includes phenotypes in which erythrocytes react weakly with the anti-A and ndashB
reagents for example A3 Ax Afinn Ael B3 Bx Bv Bel cis-AB (57)
It is difficult to determine clearly their specific ABO subgroup by conventional
serological methods The weak subgroups are important in more than one way First
they risk complicating patient and donor blood group determination At worst the
wrong group can be assigned if eg a weak antigen is missed Second they allow us to
characterize and understand glycosyltransferase mechanisms by studying the results of
mutations in the underlying alleles
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
35
2431 Weak A alleles
The RBCs from individuals with the A3 phenotype agglutinate strongly with
anti-A and anti-AB in vitro but show a large number of free cells One A3B individual
had a novel point mutation 871GrarrA (Asp291Asn) on the A1 [A101] (58) and this
allele was named A301 Ax alleles are responsible for the rare subgroup Ax and the
RBCs typically show a weak positive reaction with anti-AB and anti-H There are four
base substitutions involved in these alleles 646TrarrA (Phe216Ile) 681GrarrA (silent)
771CrarrT (silent) 829GrarrA (Val277Met) The encoded transferase is expected to be 37
aa longer than the normal consensus allele and 16 aa longer than A2-encoded
transferase The serological characteristics of some other minor phenotypes included
among A subgroups eg Aend Am Ay Afinn Abantu and the collective description Aw are
more unclear Table 22 shows the serological reaction patterns of weak A alleles
Table 22 Serological reaction patterns
A negative reaction is noted by 0 and positive reactions are denoted from + (very weak
agglutination) to 4+ (maximal agglutination)mf mixed field agglutination
2432 Weak B alleles
B variants are much more uncommon than A variants this may reflect the
relatively low frequency of the B blood group in many populations These phenotypes
Subgroup
of A
RBC reactions with Anti-A1
in serum
Anti-A Anti-AB Anti-A1 Anti-H
A1 4+ 4+ 4+ 0 No
A2 4+ 4+ 0 4+ Sometimes
Aint 4+ 4+ 2+3+ 2+3+ No
A3 2++mf 2++ mf 0 4+ No
Ax 0+ 2++ 0 4+ Often
Ael 0 0 0 4+ Sometimes
Aend + + 0 4+ Sometimes
Afinn + + 0 4+ Yes
Abantu +(+) +(+) 0 4+ Yes
Am 0+ 0+ 0 4+ No
Ay 0 0 0 4+ No
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
36
often appear to result from missense mutations at the ABO locus causing single aa
changes in the GTB Characteristics of some B variants are summarized in Table 23
(57)
Table 23 Characteristics of some more frequent B weak phenotypes
mf mixed field w very weak agglutination
The B3 phenotype have missense mutation 1054CrarrT (Arg352Trp) on a B1
(B101) background and named B301 (58) A Bx allele responsible for the Bx phenotype
had a point mutation at nt 871GrarrA (Asp291Asn) (59) which was also found in an A3
sample (58) The Bel phenotype was divided into two suballeles Bel-1 and Bel-2 (Bel01
and Bel02) which had substitutions at 641TrarrG (Met214Arg) and 669GrarrT
(Glu223Asp) respectively (59) these missense mutations reduce the enzymatic
activities of the GTB Ogasawara et al (1996) also found another B3 allele B302 which
differs from B consensus by two nucleotide substitutions 646TrarrA (Phe216Ile) and
657TrarrC
CisAB alleles rare phenotype was described by Seyfried in 1964 It represents a
very interesting phenomenon that proved that it is possible for a child with blood group
O to have a parent with blood group AB Seyfried hypothesized that both A and B
determinants of the AB blood group could be located on the same chromosome Later
on this hypothesis confirmed in that the existence of an exceptional ABO allele
encoding a glycosyltransferase is indeed able to produce both A and B enzymes at the
same time (57) Cis-ABO1 was sequenced and showed the substitution 803GrarrC
(Gly268Ala) on the A1-2 (A102) background and thus can be described as AAAB (60)
Another allele named cis-ABO2 was discovered when a Vietnamese man who was to
undergo organ transplantation showed irregular blood grouping results The sequencing
Subgroup
of B
RBC reactions with Anti-B
in serum
Anti-A Anti-AB Anti-B Anti-H
B 0 ++++ ++++ ++ None
B3 1 mf mf +++ None
Bx 1 w w +++ Yes
Bel 0 w 0w +++ None
Bm 0 0 0 +++ Sometimes
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
37
showed that his ABO genes were nearly identical to the normal B allele except for a
796ArarrC (Met266Leu) substitution (61)
25 ABO antibodies
Antibodies are immunoglobulin proteins secreted by B-lymphocytes after
stimulation by a specific antigen The antibody formed binds to the specific antigen in
order to mark the antigen for destruction The type of antigenic exposure occurring in
the body determines if the antibody is a naturally occurring or immune antibody The
term lsquonaturally occurringrsquo is used for blood group antibodies produced in individuals
who have never been transfused with red cells carrying the relevant antigen or been
pregnant with a fetus carrying the relevant antigen Naturally occurring antibodies can
be formed after exposure to environmental agents that are similar to red cell antigens
such as bacteria dust or pollen (62)
Most of these antibodies are not clinically significant with the exception of ABO
antibodies It is possible that food and environmental antigens (bacterial viral or plant
antigens) have epitopes similar enough to A and B glycoprotein antigens The
antibodies created against these environmental antigens in the first years of life can
cross-react with ABO-incompatible red blood cells (RBCs) that it comes in contact with
during blood transfusion later in life Anti-A antibodies are hypothesized to originate
from immune response towards influenza virus whose epitopes are similar enough to
the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction
Anti-B antibodies are hypothesized to originate from antibodies produced against
Gram-negative bacteria such as E coli cross-reacting with the α-D-galactose on the B
glycoprotein (49) Anti-A and anti-B antibodies (called isohaemagglutinins) which are
not present in the newborn appear in the first years of life They are isoantibodies that
are produced by an individual against antigens produced by members of the same
species (isoantigens) Anti-A and anti-B antibodies are usually IgM type which are not
able to pass through the placenta to the fetal blood circulation and react best at room
temperature or lower The ABO antibodies may also be found in various body fluids
including saliva milk cervical secretions tears and cysts These antibodies are
detected at about 3 months and increase their titer until the 5th
to 10th
year of life
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
38
Sera from A individuals contain anti-B antibody while B individuals sera
contain two types of antibody against A antigens The first is anti-A and the second one
is specific towards A1 RBCs Anti-A reacts with both A1 and A2 cells whereas the
second only does with A1 RBCs Anti-A1 is also present in some A2 and A2B
individuals (63) Group O people produce an antibody anti-AB able to cross-react with
both A and B RBCs
26 Studies on ABO Genotype
Olsson et al (1995) studied the ABO genotype in 300 Danish blood donors with
a method using six restriction enzyme digestions following three different PCRs
detecting polymorphism at nucleotide positions (nt) 261 526 and 703 The results of the
study showed that about 3 of the O alleles were of the new type of O gene O1 The
common O allele was assigned O2 They found a restriction enzyme site for HpaIl that
is only present in non-B O2 alleles (64)
Fukumori et al (1995) performed the genotyping of ABO blood groups on a
Japanese population using the polymerase chain reaction (PCR) method The 4 DNA
fragments containing the nucleotide position 261 526 703 and 796 of cDNA from A-
transferase were amplified by PCR and the amplified DNA was subjected to restriction
fragment length polymorphism (RFLP) analysis The different nucleotide at position
803 was distinguished by electrophoresis of the PCR products amplified with allele-
specific primers By analyzing the electrophoresis patterns The frequencies of ABO
genotypes found in Japanese blood donors with A and B phenotypes were as follows in
the phenotype A group AA =198 and AO = 802 and in the phenotype B group
BB =128 and BO=872 (65)
Ogasawara et al (1996) investigated the polymorphism of the ABO blood
group gene in 262 healthy Japanese donors by a polymerase chain reaction-single-strand
conformation polymorphism (PCR-SSCP) method and 13 different alleles were
identified The number of alleles identified in each group was 4 for A1 (called ABO
A101 A102 A103 and A104) 3 for B (ABO B101 B102 and B103) and 6 for O
(ABO O101 O102 O103 O201 O202 and O203) Nucleotide sequences of the
amplified fragments with different SSCP patterns were determined by direct
sequencing These alleles were classified into three major lineages AO1 B and O2 In
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
39
Japanese A102 and B101 were the predominant alleles with frequencies of 83 and
97 in each group respectively whereas in group O two common alleles O101 (43)
and O201 (53) were observed (44)
Akane et al (1996) isolated DNA from peripheral blood leukocytes of 24
unrelated Japanese individuals ABO phenotypes of these samples were identified by
serological methods Using primers 200 base-pair (bp) fragment of ABO locus was
amplified by PCR which spans the site of the single nucleotide deletion associated with
O allele O allele identified by Kpn I digestion of the PCR product A and B alleles were
distinguished by Mae II digestion of the product The nucleotide substitution in the 200-
bp product between A and B alleles was also found in O allele resulting in 2 different
suballeles OA and O
G (66)
Al-Bustan et al (2002) genotyped the ABO blood group system in a Kuwaiti
population sample using polymerase chain reactionmdashrestriction fragment length
polymorphism (PCR-RFLP) analysis The positions of nucleotides 258 and 700 of
cDNA from A transferase were amplified by PCR The amplified DNA was subjected
to RFLP analysis to distinguish A B and O alleles Blood samples of known ABO
phenotype from 101 healthy unrelated Kuwaiti individuals (A 29 B 23AB 14 O 35)
were used Two DNA fragments of the ABO locus were designed to be amplified by 2
pairs of primers To identify the 258th nucleotide a 199- or 200-bp DNA fragment was
amplified by PCR and digested with KpnI For the 700th nucleotide a 128-bp DNA
fragment was amplified by PCR and digested with AluI By analyzing the
electrophoresis patterns the DNA fragments were examined The result of the study
showed that ABO genotypes of the known 101 samples were as follows AA 430
AO 2441 BB 416 BO 242 AB 846 and OO 3465 (67)
Seltsam et al (2003) analyzed the complete genomic sequences except intron
1 and 2 regulatory regions of 6 common (ABOA101 ABOA201 ABOB101
ABOO01 ABOO02 and ABOO03) and 18 rare ABO alleles by phylogenetic
analysis and correlating sequence data with the ABO phenotypes They revealed
multiple polymorphisms in noncoding regions The analysis revealed 5 main lineages
ABOA ABOB ABOO01 ABOO02 and ABOO03 Phenotype-genotype
correlation showed that sequence variations within the complete coding sequence can
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
21
affect A and B antigen expression All variant ABOAB alleles and one new
ABOO03- like allele were associated with weak ABO phenotypes (10)
Natsuko et al (2004) studied ABO genotypes from samples obtained from 1134
randomly selected Japanese peripheral blood samples A simple ABO genotyping
method using multiplex sequence-specific PCR and capillary electrophoresis was
developed as a supplement to serological ABO typing They found a concordance rate
of 9982 (11321134 samples) between genotypes and phenotypes defined as groups
A B AB and O Sequencing analysis revealed that one discrepant sample contained an
O allele having a point mutation at the primer binding site in exon 6 and another
discrepant sample contained an O allele lacking the guanine deletion at nt 261 (the
O301 allele) (68)
K Honda et al (2004) determined the ABO genotypes of 958 DNA samples
extracted from individuals living in Japan Mongolia and Colombia by using Single-
Strand Conformation Polymorphism (SSCP) which detects only one-base difference
between different genotypes The denatured single-stranded amplicons were
electrophoresed in sequencing gel analyzed by laser detector and visualized the peak
patterns of chromatogram As a result they were able to classify ABO genotypes into
15 groups and additional subtypes Ten kinds of fundamental genotypes (AA AOA AO
G
BB BOA BO
G O
AO
A O
AO
G O
GO
G and AB) by the combination of a base substitution
of np261 (Gdel) and np297 (A G) were detected In addition examination of 400 DNA
samples from Japan Mongolia and Columbia revealed a remarkable regional deviation
in allele frequency of A101 versus A102 and OA vs O
G (69)
Hanania et al (2007) determined the phenotypic allelic frequencies and the
genotypes of ABO blood groups in a Jordanian population Samples of 12215 randomly
healthy Jordanian voluntary blood donors during the period 1998-2003 were taken from
the National Blood Bank donor registry Amman Jordan The results of the phenotypic
distribution indicated that 4686 (3836) of the donors were type A 4473 (3662) O
2203 (1804) B and 853 (698) AB The gene frequencies were 06052 for Io allele
02607 for Ia allele and 01341 for I
b allele Using PCR-RFLP technique two separate
segments of the transferase gene containing nucleotide 261 in exon 6 and nucleotide
703 in exon 7 of the ABO gene locus were amplified and their products were analyzed
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
23
with two restriction enzymes (KpnI and AluI) The electrophoresis patterns of 105
samples showed that ABO genotypes were AA 6 (5714) AO 35 (33333) BB 1
(0953) BO 14 (13333) AB 10 (9524) and OO 39 (37143) (70)
EL-Zawahri and Luqmani (2008) examined the genotype of a 355 unrelated
blood donors of phenotype A1 (46) A2 (31) A1B (6) A2B (4) B (97) and O (171) by
using a multiplex PCR-RFLP technique in a Kuwaiti Arab cohort DNA fragments of
252 (251 for O1) and 843 (842 for A2) bp spanning the two major exons 6 and 7 of the
ABO gene were amplified and digested with HpaII and KpnI They identified 13
different genotypes combining the A1 A2 B O1 and O2 alleles from the digestion
patterns 1 A1A1 (028) 6 A1A2 (169) 38 A1O1 (1071) 1 A1O2 (028) 1 A2A2
(028) 30 A2O1 (845) 6 A1B (169) 4 A2B (113) 12 BB (338) 79 BO1
(2225) 6 BO2 (169) 167 O1O1 (4704) and 4 O1O2 (113) Two of the
combinations (A2O2 O2O2) were not found (71)
Sung et al (2009) evaluated ABO genotypes via multiplex allele-specific PCR
(ASPCR) amplification using whole blood samples without DNA purification of 127
randomly chosen samples The genotypes of the 127 samples were found to be A1A2
(n=1) A2A2 (n=9) A1O1 (n=3) A2O1 (n=12) A2O2 (n=14) B1B1 (n=5) B1O1 (n=18)
B1O2 (n=15) O1O1 (n=14) O2O2 (n=8) O1O2 (n=14) and A2B1 (n=14) from which
phenotypes were calculated to be A (n=39) B (n=38) O (n=36) and AB (n=14) They
found no discrepancies when the multiplex AS-PCR assay results were compared with
the serologically determined blood group phenotypes and genotypes determined by
DNA sequencing (72)
Nojavan et al (2012) examined the genotype of 744 randomly selected samples
from Azari donors of East Azerbaijan province (Iran) using multiplex allele-specific
PCR ABO genotyping technique As a result the ABO blood group genotypes were
12 A1A104 A1A2 4A1B1 24 A1O1 141 A1O2 32 A2A2 6A2B152
A2O1 69 A2O2 16 B1B1 113 B1O1 105 B1O2 93 O1O1 153 O1O2
85 O2O2 (73)
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
22
Bugert et al (2012) determined the major ABO alleles by PCR amplification
with sequence-specific primers (PCR-SSP) in a representative sample of 1335 blood
donors in Germany The genotypes were compared to the ABO blood groups registered
in the blood donor files Then the ABO phenotypes and genotypes were determined in
95 paternity trio cases that have been investigated They found that the prevalence of
the major ABO alleles and genotypes corresponded to the expected occurrence of ABO
blood groups in a Caucasian population In 12 of 35 exclusion cases (343) the ABO
genotype also excluded the alleged father whereas the ABO phenotype excluded the
alleged father only in 7 cases (20) (74)
27 ABO Genotyping and Susceptibility to Diseases
The presence of the A and B blood group antigens expressed on red blood cells
and other cells and molecules within the body has been associated with susceptibility to
diseases like cancer leukemia cardiovascular disease and risk of both arterial and
venous thrombosis Most studies indicated an increased risk of thrombosis associated
with the non-O blood group (7576) Nonndashgroup O patients have a greater risk of
venous thromboembolism (VTE) than patients of group O and have greater levels of
von Willebrand factor (vWF) and factor VIII (7577) The risk of VTE is probably
related to the level of vWF and factor VIII because patients of group A2 have lower
levels of these proteins than A1 B and AB and have a lower risk of VTE (76) A B
and H blood group antigens are expressed on N-glycans of vWF and influence the half-
life of the protein providing an explanation for the greater levels in non-O patients
which increase clot formation in non-O patients (78)
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
21
CHAPTER 3
MATERIALS amp METHODS
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
24
CHAPTER 3
MATERIALS amp METHODS
31 Materials
311 PCR primers
The nucleotide sequence of the PCR primers used in the current study was as
described by Yamamoto et al (79) The nucleotide substitutions in the primers are
focused on the nucleotide positions 261 297 467 and 803 so as to discriminate
between the A101 A102 B101 O01 O02 and cis-ABO1 alleles Table 31 shows the
oligonucleotide primer sequences their combinations amplification product lengths
and allele specificities The 3prime base of each primer (except int6) was designed to
correspond to the nucleotides at positions 261 297 467 and 803 which define the
polymorphisms
Table 31 PCR primers sequence used for ABO genotype
PCR
reaction
Primer pair Fragment
size (bp)
Allele specificity
1 261G 5prime-GCAGTAGGAAGGATGTCCTCGTGTTG-3prime 205 A101 A102 B101 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 A101 O01 O02
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
2 297A 5prime-CCATTGTCTGGGAGGGCCCA-3prime 164 A101 A102 O01 cis-ABO1
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467C 5prime-CCACTACTATGTCTTCACCGACCATCC-3prime 381 B101
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
3 261A 5prime-GCAGTAGGAAGGATGTCCTCGTGTTA-3prime 205 O01 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 A102
803G 5prime-CACCGACCCCCCGAAGATCC-3prime
4 297G 5prime-CCATTGTCTGGGAGGGCCCG-3prime 164 B101 O02
int6 5prime-AGACCTCAATGTCCACAGTCACTCG-3prime
467T 5prime-CCACTACTATGTCTTCACCGACCATCT-3prime 381 cis-ABO1
803C 5prime-CACCGACCCCCCGAAGATCG-3prime
The primers are named based on the position of their 3prime end relative to the cDNA sequence of A101 allele
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
25
312 Kits
DNA extraction kit (Promega USA)
313 Reagents and Chemicals
Anti A (Plasmatec Monoclonal UK)
Anti B (Plasmatec Monoclonal UK)
Agarose Molecular biology grade (Promega USA)
DNA molecular weight marker 50 bp-ladder (Promega USA)
EDTA disodium salt (Promega USA)
Absolute Ethanol (Sigma USA)
Ethidium bromide (Promega USA)
Absolute Isopropanol (Sigma USA)
Tris base hydroxyl methyl amino methane (Promega USA)
DNAse RNAse free water (Promega USA)
Acetic acid (Sigma USA)
PCR Master mix (Promega USA)
314 Apparatus and Equipments
Thermal Cycler (Biometra Germany)
LG Microwave Oven
Electrophoresis Apparatus
Vortex Mixer
Digital Camera
Power Supply (Biorad)
Freezer Refrigerator
Micro-Centrifuge
Hoefer shortwave UV light table (Transilluminator)
Computer
Electrical Balance
Automatic Micropipettes
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
26
32 Methods
321 Study population
322 Sample collection
Blood samples were collected from 201 subjects recruited from the Islamic
University ndashGenetics Laboratory Each sample was collected into EDTA tube The
EDTA samples were kept at 4degC and were used within 24 hours for forward blood
grouping and DNA extraction and subsequent PCR analysis
323 Ethical Considerations
An authorization to carry out the study was obtained from a local ethics
committee using an agreement letter prepared by the Islamic University of Gaza All the
information that were obtained about the subjects were kept confidential
324 Data Analysis
The data were entered stored and analyzed by personal computer using the
Statistical Package for Social Sciences (SPSS) version 160 Allele frequencies were
calculated under the assumption of HardyndashWeinberg equilibrium and expressed as
percentages Chi-square test was used to compare observed allelic and genotypic
frequency distributions of the blood group antigens to that expected under the Hardyndash
Weinberg equation P values gt005 were considered statistically significant
The frequency of ABO in the studied population were compared with the
frequency of ABO in some neighbor countries
33 Blood ABO-typing
331 Forward blood group
Whole blood sample (50 microl) was mixed with Anti A and Anti B reagents by
using slide method in the proportions shown in Table 32 below
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
27
Table 32 Sample Anti A Anti B reaction for forward blood grouping
Sample Anti -A Anti -B
50 microl 50 microl ــــــ
50 microl 50 ــــــ microl
The contents of each slide were rotated then the agglutination (if present) was
read by naked eye after 30 seconds
34 ABO Genotyping
341 DNA Extraction DNA was isolated from fresh EDTA whole blood cells by using Promega kit for
human DNA isolation The kit contains the following components that are enough for
purifying genomic DNA from 200 samples of human blood
Cell lysis solution
Nuclei lysis solution
Protein precipitation solution
DNA rehydration solution
RNase solution
The human genomic DNA was isolated from human blood sample according to
the kit instructions and was as follows
Three hundred microl EDTA blood were transferred into a sterile 15 ml micro-
centrifuge tube containing 900 microl of cell lysis solution The tube was inverted 5-6 times
to mix the components The mixture was incubated for 10 minutes at room temperature
(with gentle mixing once during the incubation) to lyse the red blood cells The tube
was then centrifuged at 13000 rpm for 20 seconds at room temperature
Supernatant was removed and discarded as much as possible without disturbing
the visible white pellet Approximately 10-20 microl of residual liquid should be left in tube
The tube was vortexed vigorously until the white blood cells were completely
resuspended Three hundred microl of nuclei lysis solution was then added to the tube
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
28
containing the resuspended cells and the suspension was mixed by pipetting the solution
5-6 times to lyse the white blood cells the solution should become very viscous
RNase solution (15 microl) was added to nuclear lysate and the sample was mixed
by inverting the tube 2-5 times The mixture was incubated at 37degC for 15 minutes and
then cooled to room temperature One hundred microl of protein precipitation solution was
added to the nuclear lysate and the mixture was vortexed vigorously for 10ndash20
seconds Small protein clumps may be visible after vortexing and were removed by
centrifuge precipitation at 13000 rpm for 3 minutes at room temperature The
supernatant was transferred to a clean 15 ml micro-centrifuge tube containing 300microl
isopropanol at room temperature The mixture was gently mixed by inversion until the
white thread-like strands of DNA form a visible mass The DNA was then precipitated
by centrifugation at 13000 rpm for 1 minute at room temperature The DNA would be
visible as a small white pellet
The supernatant decanted and one volume of 70 ethanol was added to the
DNA and kept at room temperature and gently inverted several times to wash the DNA
pellet and the sides of the micro-centrifuge tube After centrifugation at 13000 rpm for
1 minute the ethanol was aspirated using a suitable pipette The DNA pellet is very
loose at this point and care must be used to avoid aspirating the pellet into the pipette
The tube was inverted on a clean absorbent paper for 10ndash15 minutes in order to air-dry
the pellet DNA rehydration solution was added to the dry pellet and the DNA was
rehydrated by incubation at 65degC for 1 hour Periodically the solution was mixed by
gently tapping the tube The DNA was then stored at 2-8degC
342 Detection of extracted DNA
The quality of the isolated DNA was determined by running 5 microl of each sample
on ethidium bromide stained 30 agarose gels and the DNA was visualized on a short
wave UV transilluminator the results were documented by photography
35 PCR reactions
PCR was performed using the primers listed in Table 31 in 4 micro-tubes as
described by Sung Ho Lee et al (70) For each PCR 5 μl master mix (Promega) 2 μl
deionized water 1 μl DNA template and 05 μl of each allele specific primer (5 pmol) in
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
29
one micro-tube (02 ml) were mixed The volume and concentration of a typical PCR
reaction are shown in Table 32
PCR was performed in a thermal cycler The cycling conditions were as
described below In each PCR MTHFR gene specific primers with the following
sequences (Forward 5prime-ACGATGGGGCAAGTGATGCCC -3 and reverse 5-
GAGAAGGTGTCTGCGGGATC-3) were used as a positive control that produces a 95
bp fragment Upon completion of PCR the products were analyzed by electrophoresis
on 2 ethidium bromide stained agarose gel or stored at 4degC until analysis
Table 33 Composition of PCR master mix
Reagent Composition
dNTPs 400microM each dATP dGTP dCTP dTTP
Taq DNA Polymerase 50 units ml
MgCl2 2mM
351 Temperature cycling program
The thermal cycler program was set as follows
Step 1 Denaturation for 3 minutes at 95degC
Step 2 35 cycles of
21 Melting for 40 seconds at 95degC
22 Annealing for 40 seconds at 585degC
23 Extension for 40 seconds at 72degC
Step3 Final elongation for 5 minutes at72degC
352 Expected PCR results
The PCR product size was estimated by comparing it with DNA molecular size
marker (50 bp ladder DNA ) run on the same gel
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
11
CHAPTER 4
RESULTS
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
13
CHAPTER 4
RESULTS
41 Study Population
The study population consisted of 201 subjects (50 males 151 females ) The
percentage of males was 249 while that of females was 751 ( figure 41)
0
10
20
30
40
50
60
70
80
maleFemale
Figure 41 Distribution of the study subjects according to gender
42 Phenotypic Frequency of ABO Blood Groups
Blood grouping was done by antigen antibody agglutination test by using
commercial monoclonal antisera The distribution of phenotypes in the total sample
were 363 (73) 224 (45) 75 (15) 338 (68) for groups A B AB and O
respectively Group A was the dominant one in both genders and AB was the rarest in
both males and females ( table 41)
Table 41 Phenotypic frequencies of various blood groups in the study population
Subject Sex Phenotype
Total A B AB O
Male 16 10 4 20 50
Female 57 35 11 48 151
Total 73 45 15 68 201
753
249
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
12
43 The Allele Frequencies of ABO Antigens
Allele frequency for the antigens was computed by the Hardy-Weinberg law on
the basis of the number of subjects with blood groups ABO The distribution of the
alleles in the total samples was 025 017 058 for IA I
B and I
O respectively
All genotyping results were compatible with the determined phenotypes by
serological method The observed genotypes as compared with the expected genotypes
are shown in Table 42 The frequencies of the five alleles in the our sample population
were O1 and O2 alleles 0376 and 0221 respectively while A1 0174 A2 0067
B 0162
Table 42 Observed and expected genotypes for the 201 samples
P-Value Expected Observed
Genotype Phenotype Percent Number Percent Number
0230 63 126 45 9 AA A
04762 29 583 318 64 AO
07205 29 58 25 5 BB B
09496 197 396 199 40 BO
05915 85 1708 75 15 AB AB
09613 336 676 338 68 OO O
100 201 100 201 Total
The statistical analysis ( using chi square test ) indicated that molecular data
were in good agreement with the ratio calculated from the estimated gene frequencies of
the ABO blood group system in the Gaza Strip population
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
11
44 PCR Results
441 Quality of the isolated DNA
Regarding the method of DNA isolation that was described in chapter 3 the
quality and quantity of DNA were suitable for PCR processing The quality of the
isolated DNA from human subjects is represented in the following figure (42)
Figure 42 A representative photograph of DNA isolated from human blood The samples were
run on 1 agarose gel stained with ethidium bromide
442 Blood group genotyping by Allele Specific PCR
Multiplex Allele Specific PCR (ASPCR) assay contains four independent PCR
reactions (Table 31) In the first reaction 261G-int6 primer pair was used to amplify
the 205 bp fragment to detect the A101 A102 B101 cis-ABO1 alleles and the 467C-
803G primer pair was selected to amplify the 381 bp fragment to detect the A101 O01
and O02 alleles The 297A-int6 primer pair and the 467C-803C primer pair in the
second reaction were selected to amplify the 381 bp fragment to detect the B101 allele
In the third reaction the 261A-int6 primer pair was selected to amplify the 205 bp
product to detect the O01 and O02 alleles and the 467T-803G primer pair was selected
to amplify the 381 bp product to detect the A102 allele Finally in the fourth reaction
the 297G-int6 primer pair were applied to produce the 164 bp fragment to detect the
B101 and O02 alleles and the 467T-803C primer pair to produce the 381 bp fragment
to recognize the cis-ABO1 allele Table 43 show the products of PCR reactions
according to the genotype
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
14
Table 43 PCR products according to the genotype
PCR Reactions Genotype
R1 R2 R3 R4
381 164 205 _ O1O1
381 _ 205 164 O2O2
381 164 205 164 O1O2
205 381 _ 164 B1B1
381205 381164 205 164 B1O1
381205 381 205 164 B1O2
381205 381164 _ 164 A1B1
205 381164 381 164 A2B1
381205 164 _ _ A1A1
381205 164 205 _ A1O1
381205 164 205 164 A1O2
381205 164 381 _ A1A2
205 164 381 _ A2A2
381205 164 381205 _ A2O1
381205 164 381205 164 A2O2
Random mating with the six different alleles at the ABO locus can result in 21
different genotype combinations Only 15 different genotype combinations were
detected from the 201 investigated samples (Figure 43)
A- 1 O1O1 2 O2O2
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
15
B- 1 B1B1 2 O1O2
C- 1 B1O1
2 A1B
D- 1 A1A2 2 A2O2
E- 1 A1O1 2 A1A1
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
16
F- 1 A1O2 2 B1O2 3 A2A2
G- 1 A2O1
2 A2B1
Figure 43 The electrophoresis pattern of recognized genotypes using the multiplex ASPCR
method This figure shows 15 different genotypes lane M indicates the 50 bp ladder The R1-
R4 show the PCR reaction number
443 Genotype Frequencies
The frequency of ABO recognized genotypes belonging to the population
residing in Gaza Strip are shown in table 44 As shown in the table the highest allele
frequencies in A B AB and O phenotypes were A1O2 (124) B1O1 (129) A1B
(55) and O1O1 (154) respectively
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
17
Table 44 The frequency of recognized genotypes using multiplex ASPCR method for a
population residing in Gaza Strip
Genotype Frequency Percent
A1A1 3 15
A1O1 24 119
A1O2 25 124
A1A2 4 20
A2A2 2 10
A2O1 13 65
A2O2 2 10
B1B1 5 25
B1O1 26 129
B1O2 14 70
A1B 11 55
A2B 4 20
O1O1 31 154
O1O2 26 129
O2O2 11 55
Total 201 1000
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
18
CHAPTER 5
DISCUSSION
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
19
CHAPTER 5
DISCUSSION
Since the first delineation of the molecular basis of the ABO blood group by
Yamamoto et al (11 79) it has become possible to determine the ABO genotypes using
molecular methods without the need for family investigations ABO genotyping is
commonly used in cases of an ABO discrepancy between cell typing and serum typing
as well as in forensic practices for personal identification and paternity testing (72) The
ABH antigens are ubiquitously expressed in humans and are present primarily as
glycoproteins and partly as glycolipids The ABO locus is found on the long arm
of chromosome 9 (9q341-q342)
Multiplex allele specific PCR (the technique we used here) has advantages over
PCR-RFLP in terms of cost effectiveness reaction time and simplicity of handling It is
a rapid method that is based on detecting four single nucleotide polymorphisms at
nucleotides 261 297 796 and 803 of the ABO locus which in turn discriminate the
major ABO alleles
In this study the ABO genotypes of 201 samples recruited from the Islamic
University ndashGenetics Diagnosis Laboratory were determined using multiplex AS-PCR
method The objectives of this study were to correlate ABO genotypes with phenotypes
in blood samples in a Gaza Strip population and to compare the frequency of ABO
genotypes with other populations
51 The Allele Frequencies of ABO Antigens in Gaza Strip
The frequency of the alleles in the total samples were 0250 for the I
A allele
0170 for the IB allele and 0580 for the I
O allele This distribution is in agreement with
the distribution with the samples reported in an Iranian study were they reported
023974 for IA allele 018147 for I
B allele and 057879 for I
O allele (73) The
frequencies of IA I
B and I
O alleles in our subjects are also comparable to those
reported in Iraqi and Jordanian studies where they found 0212 for IA allele 0177 for
IB allele and 06611 for I
O allele and 0270 for I
A allele 0130 for I
B allele and 060 for
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
41
IO allele respectively (8283) The results showed that the frequency of I
O allele is
higher than either IA or I
B and that of I
A is higher than I
B ie the trend is I
o ˃ I
A ˃ I
B
Our results showed that the distribution of ABO alleles in Gaza Strip is similar
to that reported for other Arabian and Iranian populations as shown in Table 44 which
represents the distribution of ABO alleles in different human populations This result
may imply that those populations share common ancestry
52 ABO Genotype Frequencies
The method employed here for blood group genotyping discriminates A1 A2 O1
O2 and B alleles All expected alleles and allelic combinations were observed in this
group except cis-ABO1 allele and its pertinent genotypes
The results obtained from AS-PCR for the investigated 201 samples showed that
the frequencies of the various ABO genotypes were AA 9 (448) AO 64 (3184)
BB 5 (249) BO 40 (199) AB 15 (746) and OO68 (3383) When compared
to other studies these percentages are close to those reported by Irshaid et al (2007) in
Jordan where they have reported the following frequencies AA571 AO33333
BB0953 BO13333 AB 952 and OO 37143 (83)
According to our results it was found that the highest frequency of A phenotype
(64738767) had the AO genotype while (9731233) were A phenotype
homozygotes (AA) Forty samples with phenotype B were recognized as heterozygous
(BO) and 5 samples with phenotype B recognized as homozygous (BB) On the other
hand (68201 338) were homozygous (OO) and 15 (746) samples were AB
heterozygotes The high heterozygosity observed in this study is mainly due to the high
frequency of the IO allele (058) in our population as compared to that of I
A (0250) and
IB (0170) alleles Additionally the samples investigated here were collected from
unrelated individuals and that allowed for the random assortment of the alleles
according to their frequencies in the population This is further confirmed by finding
that the observed genotypes did not deviate significantly from Hardy-Weinberg
equilibrium
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
43
Regarding the genotypes observed (Table 44) the highest frequency belonged
to O1O1 genotype ( as a consequence of the high frequency of O1 allele ) with a
frequency of 154 (31201) and the lowest frequency belonged to A2A2 and A2O2
genotypes ( as a result of the low frequency of A2 allele ) with a frequency of 10
(2201) each In addition 145 (7214) out of all the samples were heterozygous and 56
samples (2786) were homozygous
In our population the calculated frequencies of the O1 and O2 alleles were
03756 and 02214 respectively These values differ from those reported in other
populations eg in Kuwaiti population the reported frequencies were 06831 and
00155 for O1 and O2 respectively (80) Our findings are however consistent with
many other studies where they reported higher prevalence of the O1 allele (7380)
(Table 51)
Table 51 Frequency of ABO gene Alleles in Gaza Strip in comparison to some other countries
Reference Allele frequencies
Population r
O q
B p
A
Current study 0580 0170 0250 Gaza Strip
Mokhtar and Yunus 2008 (80) 06986 01676 01338 Kuwait
Al-Aarrayed et al 2001 (81) 0704 0157 0141 Bahrain
Tills et al 1983 (82) 06611 0177 0212 Iraq
Irashaid et al 2002 (83) 060 0130 0270 Jordan
Bashwar et al 2001 (84) 0714 01197 01663 Saudi Arabia
Khalil et al 1989 (85) 0663 0149 0188 Egypt
Khalil et al 1989 (85) 0668 0140 0192 Sudan
Nojavan et al 2012 (73) 057879 018147 023974 Iran
Meanwhile the calculated frequencies of A1 A2 and B alleles were A1
017413 A2 006716 B 016171 where these are also different in frequency from
those of the Kuwaiti study
cis-ABO1 allele was not observed in this study It is a rare allele which was
reported in Korea (00354) among blood donors (86) This allele also was not detected
in Kuwaiti or Iranian populations
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
42
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
41
CHAPTER 6
CONCLUSION and RECOMMENDATIONS
The present study focused on detection of the major ABO genotypes in a Palestinian
population residing in Gaza Strip The results of this study can be summarized as
follows
In Gaza Strip the A phenotype was the most common blood group followed by
OAB and B
The frequencies of ABO alleles in the investigated subjects were 025 for IA
017 for IB and 058 for I
O These frequencies are comparable to those obtained
from ABO genotyping
No statistically significant differences were found between the frequency of
observed and expected genotypes This proved that the ABO genotypes of the
randomly collected samples were in Hardy- Weinberg equilibrium data
Molecular data indicated that Hardy-Weinberg equation can be used to detect
the percentage of the major blood group in our population
The distribution of the ABO genotypes in Gaza Strip population is similar to that
of many Asian populations
There is no significant difference between male and female in terms of ABO
phenotypes
Our study indicated that the most common genotype is O1O1 and the lowest are
A2A2 and A2O2 The cis ABO1 was not encountered
The homozygous genotype of A and B alleles (AA BB ) were less than the
heterozygous(AO BO) genotype
The frequency of O2 allele in Gaza strip seems to be higher than that reported in
many neighboring countries
This study determined the exact phenotypic frequency of ABO blood groups in Gaza
Strip and the frequencies of the prevalent ABO alleles namely A1 A2 B1 O1 and O2
When both serological typing and ABO genotyping are performed and full
compatibility between a phenotype and a genotype is observed examiners can
determine the ABO phenotype with an even higher level of confidence Therefore we
recommend that the health care system in Palestine adopt ABO genotyping particularly
for cases of discrepant blood phenotypes
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
44
CHAPTER 7
REFERENCES
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
45
CHAPTER 7
REFERENCES
1 Hosseini-Maaf B and Pahlsson P Genetic Characterization of Human ABO Blood
Group Variants with a Focus on Subgroups and Hybrid Alleles ISBN 978-912007
2Watkins WM Biochemistry and genetics of the ABO Lewis and P blood group
systems In Harris H Hirschhorn K eds Advances in Human Genetics Vol 10 New
York Plenum Press1ndash1361981
3Larsen RD Ernst LK Nair RP Lowe JB Molecular cloning sequence and
expression of a human GDP-L-fucose β -D-galactoside 2- alpha-L-fucosyltransferase
cDNA that can form the H blood group antigen Proc Natl Acad Sci USA 87(17)
6674-66781990
4Yamamoto F Hakomori S Sugar-nucleotide donor specificity of histo-blood group A
and B transferases is based on amino acid substitution J Biol Chem 265 (31) 19257-
192621990
5 Bennett EP Steffensen R Clausen H weghuis DO Geurts van kessel A Genomic
cloning of the human histo-blood group and locus Biochem Biophys Res Commun 206
1 318-3251995
6 Watkins WM The glycosyltransferase products of the A B H and Le genes and their
relationship to the structure of the blood group antigens In Mohn JF Plunkett RW
Cunningham RK Lambert RM eds Human blood groups Basel S Karger134-42
1977
7 Hakomori SI Blood group ABH and Ii antigens of human erythrocytes chemistry
polymorphism and their developmental change Sernin Hematol1839-471981
8 Beattie KM Discrepancies in ABO grouping In A seminar on problems encountered
in pretranfusion tests Washington DC American Association of Blood Banks12965
1972
9 Yamamoto F McNeill PD Hakomori S Genomic organization of human histo
blood group ABO genes Glycobiology 51 51- 581995
10 Seltsam A Hallensleben M Kollmann A and Blasczyk R The nature of diversity
and diversification at the ABO locus Blood 102 3035-30422003
11 Yamamoto F Clausen H White T Marken J Hakamori S Molecular genetic basis
of the histoblood group system Nature 345229-2331990
12 Wade PA Gegonne A Jones PL Ballestar E Aubry F and Wolffe AP The Mi-2
histone deacetylase complex couples DNA methylation to chromatin remodeling and
histone deacetylation Nature Genetics 2362-661999
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
46
13 Lee HY Park MJ Kim NY Yang WI Shin KJ Rapid direct PCR for ABO blood
typing J Forensic Sci 56 Suppl 1S179-822011
14Storry JR Olsson ML Genetic basis of blood group diversityBr J Haematol
126759-7712004
15Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet1539-5421969
16Clausen H Hakomori S ABH and related histo-blood group antigens
immunochemical differences in carrier isotypes and their distribution Vox Sang 561-
201989
17Schenkel-Brunner H In human blood groups Springer-Verlag New York2000
18Schiffman G Kabat E A and Thompson W Immunochemical studies on blood
groups XCX Cleavage of A B and H blood-group substances by alkali Biochemistry
3113-1201964
19Rege VP Painter TJ Watkins WM and Morgan W T J Isolation of serologically
active fucose-containing oligosaccharides from human blood-group H substance Nature
(London) 203360-3631964
20Kobata A Yamashita K amp Tachibana Y Oligosaccharides from human milk
Methods in Enzymology Vol 50 pp 216-220 ISSN 0076-68791978
21Lundblad A Oligosaccharides from human urine Methods in Enzymology Vol 50
pp 226-235 ISSN 0076-68791978
22Daniels G The molecular genetics of blood group polymorphism Transpl Immunol
14 143-532005
23Blumenfeld OO Patnaik SK Allelic genes of blood group antigens a source of
human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation
Database Hum Mutat23 8-162004
24Yamamoto F McNeill P Hakomori S Human histo-blood group A2 transferase
coded by A2 allele one of the A subtypes is characterized by a single base deletion in
the coding sequence which results in an additional domain at the carboxyl terminal
Biochem Biophys Res Commun187366ndash741992
25Skacel PO Watkins WM Fucosyltransferase expression in human platelets and
leucocytes Glycocon J4267ndash721987
26 Eshleman JR Shakin-Eshleman SH Church A Kant JA Spitalnik SL DNA typing
of the human MN and Ss blood group antigens in amniotic fluid and following massive
transfusion Am J Clin Pathol103353ndash71995
27 Storry JR Reid ME Synthetic peptide inhibition of anti-STransfusion3655S1996
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
47
28 Lowe JB Red cell membrane antigens in G Stamatoyannopoulos Perlmutter
RM Majerus PW Varmus H The Molecular Basis of Blood Diseases 3rd ed
WB Saunders Orlando FL1999
29Rege VP Painter TJ Watkins WM Morgan WT Three New Trisaccharides
Obtained from Human Blood-Group a B H and Lea Substances Possible Sugar
Sequences in the Carbohydrate Chains Nature 200 532-41963
30Varki A Cummings R Esko J Freeze H Hart G and Marth J Essentials of
Glycobiology Cold Spring Harbor (NY) Cold Spring Harbor Laboratory Press ISBN-
10 0-87969-559-51999
31Jick H Slone D Westerholm B Inman WH Vessey MP Shapiro S Lewis GP
Worcester J Venous thromboembolic disease and ABO blood type A cooperative
study Lancet 1 539ndash 421969
32Taniguchi N Honke K and Fukuda M Handbook of Glycosyltransferase and
Related Genes SpringerTokyo 2002
33Henrissat B Glycosidase families Biochem Soc Trans 26153-1561998
34Schenkel-Brunner H Chester MA Watkins WM Alpha-L-fucosyltransferases in
human serum from donors of different ABO secretor and Lewis blood-group
phenotypes Eur J Biochem 30269-2771972
35Boix E Swaminathan GJ Zhang Y Natesh R Brew K Acharya KR Structure of
UDP complex of UDP galactose beta-galactoside-alpha -13-galactosyltransferase at
153-A resolution reveals a conformational change in the catalytically important C
terminus J Biol Chem 27648608-486142001
36 Breton C Snajdrova L Jeanneau C Koca J Imberty A Structures and mechanisms
of glycosyltransferases Glycobiology 1629R-37R2006
37Ramakrishnan B Boeggeman E Ramasamy V and Qasba PK Structure and
catalytic cycle of beta-14 galactosyltransferase Curr Opin Struct Biol14593
6002004
38 Barbolla L Mojena M Cienfuegos JA Escartiacuten P Presence of an inhibitor of
glycosyltransferase activity in a patient following an ABO incompatible liver transplant
Br J Haematol6993ndash61988
39 Barbolla L Mojena M Boscaacute L Presence of antibody to A- and B-transferases in
minor incompatible bone marrow transplants Br J Haematol 70471ndash61988
40 Rydberg L Samuelsson BE Presence of glycosyltransferase inhibitors in the sera of
patients with long-term surviving ABO incompatible (A2 to O) kidney grafts Transfus
Med 1177ndash821991
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
48
41Tirado I Mateo J Soria JM Oliver A Martinez-Sanchez E Vallve C Borrell M
Urrutia T Fontcuberta J The ABO blood group genotype and factor VIII levels as
independent risk factors for venous thromboembolism Thromb Haemost93468-474
2005
42 Schachter H Michaels MA Tilley CA Crookston MC Crookston JH Qualitative
differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and
A2 genes Proc Natl Acad Sci U S A70 220-41973
43Olsson ML Irshaid NM Hosseini-Maaf B Hellberg A Moulds MK Sareneva H
Chester MA Genomic analysis of clinical samples with serologic ABO blood grouping
discrepancies identification of 15 novel A and B subgroup alleles Blood 98 1585- 93
2001
44Ogasawara K Bannai M Saitou N Extensive polymorphism of ABO blood group
gene three major lineages of the alleles for the common ABO phenotypes Hum Genet
97777-7831996
45Ogasawara K Yabe R Uchikawa M Nakata K Watanabe J Takahashi Y
Recombination and gene conversion-like events may contribute to ABO gene diversity
causing various phenotypes Immunogenetics 53 190-1992001
46Ogasawara K Yabe R Uchikawa M Bannai M Nakata K Takenaka M Takahashi
Y Juji T Tokunaga K Different alleles cause an imbalance in A2 and A2B phenotypes
of the ABO blood group Vox Sang 74242- 2471998
47Rosendaal FR Risk factors for venous thrombotic disease Thromb Haemost
82610-6191999
48Lewis JD Meehan RR Henzel WJ Maurer-Fogy I Jeppesen P Klein F Bird A
Purification sequence and cellular localization of a novel chromosomal protein that
binds to methylated DNA Cell Jun 1269(6)905ndash9141992
49Mifsud NA Watt JM Condon JA A novel cis-AB variant allele arising from a
nucleotide substitution A796C in the B transferase gene Transfusion 401276-1277
2000
50Olsson ML Chester MA Frequent occurrence of a variant O1 gene at the blood
group ABO locus Vox Sang 7026-301996
51Ki K Iwata M Tsuji H Takagi T Tamura A Ishimoto G Ito S Matsui K Miyazaki
T A de novo ecombination in the ABO blood group gene and evidence for the
occurence of recombination products Hum Genet 99454-4611997
52Hosseini-Maaf B Hellberg A Rodrigues MJ ABO Exon and intron analysis in
individuals with the A weak B phenotype reveals a novel O1v-A2 hybrid allele that
causes four missense mutations in the A transferase BMC Genet 4172003
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
49
53Zago MA Tavella MH Simoes BP Racial heterogeneity of DNA polymorphisms
linked to the A and the O alleles of the ABO blood group gene Ann Hum Genet6067-
721996
54Olsson ML Santos SE Guerreiro JF Zago MA Chester MA Heterogeneity of the
O alleles at the blood group ABO locus in Amerindians Vox Sang7446-501998
55Yamamoto F McNeill PD Yamamoto M Hakomori S Bromilow IM Duguid JK
Molecular genetic analysis of the ABO blood group system 4 Another type of O allele
Vox Sang64175-81993
56 Schwyzer M and Hill R L J Biol Chem 252 2346ndash23551977
57Pusztai A and Morgan W T J Studies in immunochemistry 22 Amino acid
composition of human blood-group AB H and Le-a specific substances Biochem J
88546-5551963
58Yamamoto F McNeill PD Amino acid residue at codon 268 determines both
activity and nucleotide-sugar donor substrate specificity of human histo-blood group A
and B transferases in vitro mutagenesis study J Biol Chem 271 10515-201996
59Yamamoto F McNeill PD Yamamoto M Hakomori S Harris T Judd WJ
Davenport RD Molecular genetic analysis of the ABO blood group system 1 Weak
subgroups A3 and B3 alleles Vox Sang 64116- 1191993
60 Olsson ML Thuresson B Chester MA An Ael allele-specific nucleotide insertion
at the blood group ABO locus and its detection using a sequence-specific polymerase
chain reaction Biochem Biophys Res Commun 216642-6471995
61Ogasawara K Yabe R Uchikawa M Saitou N Bannai M Nakata K Takenaka M
Fujisawa K Ishikawa Y Juji T Tokunaga K Molecular genetic analysis of variant
phenotypes of the ABO blood group system Blood 882732-27371996
62Yamamoto F McNeill PD Kominato Y Yamamoto M Hakomori S Ishimoto S
Nishida S Shima M Fujimura Y Molecular genetic analysis of the ABO blood group
system 2 cis-AB alleles Vox Sang 64120-1231993
63Coutinho A Kazatchkine MD Avrameas S Natural autoantibodies Curr Opin
Immunol 78121995
64Olsson ML Chester MA A rapid and simple ABO genotype screening method using
a novel BO2 versus AO1 discriminating nucleotide substitution at the ABO locus Vox
Sang 69242-2471995
65Fukumori Y Ohnoki S Shibata H Yamaguchi H and Nishimukai H Genotyping
of ABO blood groups by PCR and RFLP analysis of 5 nucleotide positions Medicine
International Journal of Legal Medicine Volume 107 Number 4 179-1821995
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
51
66Akane A Yoshimura S Yoshida M Okii Y Watabiki T Matsubara K and Kimura
K ABO Genotyping Following a Single PCR Amplification Journal of Forensic
Sciences Vol 41 No 2 March pp 272-2741996
67Al-Bustan S El-Zawahri M Al-Azmi D and Al-Bashir A Allele Frequencies and
Molecular Genotyping of the ABO Blood Group System in a Kuwaiti Population
International Journal of Hematology Volume 75 Number 2 147-1532002
68Mizuno N Ohmori T Sekiguchi K Kato T Fujii T Fujii K Shiraishi T Kasai K
and Sato H Alleles Responsible for ABO Phenotype-Genotype Discrepancy and Alleles
in Individuals with a Weak Expression of A or B Antigens Forensic Sci Jan Vol 49
No 12004
69Honda K Nakamuraa T Tanakaa E Yamazakib K Tuna Z Misawab S Graphic
SSCP analysis of ABO genotypes for forensic application International Congress
Series 1261 586ndash5882004
70 Hanania SS Hassawi DS Irshaid NM Allele frequency and molecular genotypes
of ABO blood group system in a Jordanian population MedSci January 7(1) 51-58
2007
71EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2 B
O1 and O2 alleles of the ABO blood group system in a Kuwaiti population International
Journal of Hematology Apr87(3)303-92008
72Lee SH Park G Yang YG Lee SG and Kim SW Rapid ABO Genotyping Using
Whole Blood without DNA Purification Korean J Lab Med29231-72009
73Nojavan M Shamsasenjan K Movassaghpour AA Akbarzadehlaleh P Torabi SE
Ghojazadeh M Allelic Prevalence of ABO Blood Group Genes in Iranian Azari
Population BioImpacts 2(4) 207-2122012
74 Bugert P Rink G Kemp K Kluumlter H Blood Group ABO Genotyping in Paternity
Testing Transfusion Medicine Hemotherapy June 39(3) 182ndash1862012
75Jenkins PV OrsquoDonnell JS ABO blood group determines plasma von Willebrand
factor levels a biologic function after all Transfusion 46(10)1836-18442006
76Tregouet DA Heath S Saut N Andreani C Schved JF Pernod G Galan P Drouet L
Zelenika D Vague I Alessi MC Tiret L Lathrop M Emmerich J Morange PE
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO
loci to VTE risk results from a GWAS approach Blood 113(21)5298-53032009
77 Kamphuisen PW Eikenboom JCJ Bertina RM Elevated factor VIII levels and the
risk of thrombosis Arterioscler Thromb Vasc Biol21(5) 731-7382001
78Gallinaro L Cattini MG Sztukowska M Padrini R Sartorello F Pontara E
Bertomoro A Daidone V Pagnan A Casonato A A shorter von Willebrand factor
survival in O blood group subjects explains how ABO determinants influence plasma
von Willebrand factor Blood111(7)3540-35452008
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004
53
79Yamamoto F Marken J Tsuji T White T Clausen H Hakomori S Cloning and
characterization of DNA complementary to human UDP-GalNAc Fuc alpha 1----2Gal
alpha 1----3GalNAc transferase (histo-blood group A transferase) mRNA J Biol Chem
265 1146-511990
80 EL-zawahri MM Luqmani YA Molecular genotyping and frequencies of A1 A2
B O1 and O2 alleles of the ABO blood group system in a Kuwaiti population
International Journal of Hematology Apr87(3)303-92008
81 Al-Arrayed S Shome DK Hafadh N Amin S Al Mukhareq H Al Mulla M ABO
blood group and Rhd phenotypes in Bahrain Results of screening school children and
blood donors Bahrain Med Bull 23 112-52001
82 Tills D Kopec A and Tills R The distribution of the human blood groups and other
polymorphisms Suppl 1 New York Oxford University Press pp 335-401983
83 Irshaid NM Ramadan S Wester ES Olausson P Hellberg A Merza JY et al
Phenotype prediction by DNA ndashbased typing of clinically significant blood group
systems in Jordanian blood donors Vox Sang 83 55-622002
84 Bashwari LA Al-Mulhim AA Ahmad MS Ahmed MA Frequency of ABO blood
group in the eastern region of Saudi Arabia Saudi Med J 22 1008-122001
85 Khalil I Phrykian S and Farri A Blood group distribution in Sudan Gene Geogr 3
7-101989
86 Cho D Kim SH Jeon MJ Choi KL Kee SJ Shin MG Shin JH Suh SP Yazer MH
and Ryang DW The serological and genetic basis of the Cis-AB blood group in Korea
Vox Sang 87 41-32004